InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 07/25/2017

Re: whiskeysausage post# 125788

Monday, 10/23/2017 8:39:57 AM

Monday, October 23, 2017 8:39:57 AM

Post# of 459508

Wild card of course is Biogen, then 2nd place Pfizer. Did Anavex license with either of them? No one knows, but if they didn't, someone else will.



As of now we are 100% certain that there were no partnerships or licenses with either. That would be material and Anavex would have to disclose within four days of the deal's completion. Perhaps there have been conversations but nothing has come of them, yet.

Here's hoping something happens down the line though. I think BP is waiting patiently for results that are more valid (i.e. P3). They are willing to pay more for less risk. Just like Anavex is wiling to take a longer time and spend more money in P2 to minimize risk of failure in P3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News